Back
Novonesis (Novozymes A/S) 10K Form
Sell
35
NVZMY
Novonesis (Novozymes A/S)
Last Price:
$63.60
Seasonality Move:
2.34%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NVZMY News And Ratings
See the #1 stock for the next 7 days that we like better than NVZMY
NVZMY Financial Statistics
Sales & Book Value
| Annual Sales: | $4.1B |
|---|---|
| Cash Flow: | $53.9M |
| Price / Cash Flow: | 40.19 |
| Annual Sales: | $26.07 |
| Price / Book: | 2.6 |
Profitability
| EPS (TTM): | 1.13730 |
|---|---|
| Net Income (TTM): | $522.7M |
| Gross Margin: | $1.8B |
| Return on Equity: | 6.56% |
| Return on Assets: | 3.97% |
Novonesis (Novozymes A/S) Earnings Forecast
Key Novonesis (Novozymes A/S) Financial Ratios
-
The Gross Profit Margin over the past 26 years for NVZMY is 42.48%.
-
The Selling, General & Administrative Expenses for NVZMY have been equal to 19.97% of Gross Profit Margin.
-
The Research & Development expenses have been 8.70% of Revenue.
-
The Interest Expense is 28.65% of Operating Income.
-
The Net Earning history of NVZMY is 7.98% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 20 years.
Novonesis (Novozymes A/S) Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Chemicals |
| Sector: | Materials |
| Current Symbol: | NVZMY |
| Website: | novonesis.com |
Debt
| Debt-to-Equity Ratio: | 0.15 |
|---|---|
| Current Ratio: | 1.66 |
| Quick Ratio: | 1.04 |
Price-to-Earnings
| Trailing P/E Ratio: | 86.49 |
|---|---|
| Forward P/E Ratio: | 0 |
NVZMY Technical Analysis vs Fundamental Analysis
Sell
35
Novonesis (Novozymes A/S) (NVZMY)
is a Sell
Is Novonesis (Novozymes A/S) a Buy or a Sell?
-
Novonesis (Novozymes A/S) stock is rated a SellThe current Novonesis (Novozymes A/S) [NVZMY] share price is $62.25. The Score for NVZMY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.